Jeannette M Schenk

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. pmc Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial
    Jeannette M Schenk
    Fred Hutchinson Cancer Research Center, Cancer Prevention Program
    Cancer Epidemiol Biomarkers Prev 23:1484-93. 2014
  2. pmc Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?
    Jeannette M Schenk
    Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Seattle, WA 98109 1024, USA
    Am J Epidemiol 178:741-51. 2013
  3. pmc Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial
    Jeannette M Schenk
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Am J Epidemiol 176:156-63. 2012
  4. pmc Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial
    Jeannette M Schenk
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Am J Epidemiol 173:1419-28. 2011
  5. pmc Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial
    Jeannette M Schenk
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 18:1227-31. 2009
  6. pmc Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial
    Jeannette M Schenk
    Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Seattle, Washington 98109 1024, USA
    Prostate 69:1303-11. 2009
  7. pmc Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial
    Jeannette M Schenk
    Schenk, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 171:571-82. 2010
  8. pmc Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study
    Linda M Dong
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, and Department of Epidemiology, University of Washington, Seattle, WA 98109, USA
    Nutr Cancer 60:39-48. 2008
  9. doi request reprint Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial
    Alan R Kristal
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 167:925-34. 2008
  10. pmc Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial
    Alan R Kristal
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 B402, PO Box 19024, Seattle, WA 98109 1024, USA
    Am J Epidemiol 168:1416-24. 2008

Detail Information

Publications23

  1. pmc Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial
    Jeannette M Schenk
    Fred Hutchinson Cancer Research Center, Cancer Prevention Program
    Cancer Epidemiol Biomarkers Prev 23:1484-93. 2014
    ....
  2. pmc Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?
    Jeannette M Schenk
    Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Seattle, WA 98109 1024, USA
    Am J Epidemiol 178:741-51. 2013
    ..61, 0.65); however there were no cut points at which sensitivity and specificity were both above 75%. We concluded that moderate elevations in PSA, IPSS, or their rates of change should not be used as surrogate measures of incident BPH. ..
  3. pmc Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial
    Jeannette M Schenk
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Am J Epidemiol 176:156-63. 2012
    ..06 (95% CI: 0.82, 1.38). The modest associations of NSAID use with BPH risk in this cohort were probably due to confounding by indication, and NSAID use was not associated with BPH risk...
  4. pmc Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial
    Jeannette M Schenk
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Am J Epidemiol 173:1419-28. 2011
    ..This study provides the strongest evidence to date that BPH does not increase the risk of prostate cancer...
  5. pmc Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial
    Jeannette M Schenk
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 18:1227-31. 2009
    ..Further research is needed to better understand the significance of elevations in serum retinol concentrations and the possible biological mechanisms through which retinol affects prostate cancer...
  6. pmc Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial
    Jeannette M Schenk
    Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Seattle, Washington 98109 1024, USA
    Prostate 69:1303-11. 2009
    ..We examined whether adiponectin, leptin, and C-peptide were associated with incident, symptomatic BPH and whether these factors mediate the relationship between obesity and BPH risk...
  7. pmc Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial
    Jeannette M Schenk
    Schenk, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 171:571-82. 2010
    ..82; interleukin 6: OR = 1.79, 95% CI: 1.32, 2.42); these associations were only in men aged <65 years. Results suggest that systemic inflammation or lower levels of soluble receptors that bind inflammatory cytokines increase BPH risk...
  8. pmc Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study
    Linda M Dong
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, and Department of Epidemiology, University of Washington, Seattle, WA 98109, USA
    Nutr Cancer 60:39-48. 2008
    ..10-0.60). In this cohort study, use of multivitamins and single antioxidant supplements was associated with a significantly reduced risk of EA and markers of neoplastic progression among individuals with Barrett's esophagus...
  9. doi request reprint Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial
    Alan R Kristal
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 167:925-34. 2008
    ..A diet low in fat and red meat and high in protein and vegetables, as well as regular alcohol consumption, may reduce the risk of symptomatic BPH...
  10. pmc Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial
    Alan R Kristal
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 B402, PO Box 19024, Seattle, WA 98109 1024, USA
    Am J Epidemiol 168:1416-24. 2008
    ..Genetic or environmental factors that affect the activity of 5-alpha-reductase may be important in the development of symptomatic BPH...
  11. pmc A dietary intervention to elicit rapid and complex dietary changes for studies investigating the effects of diet on tissues collected during invasive surgical procedures
    Jeannette M Schenk
    Fred Hutchinson Cancer Research Center, and Department of Epidemiology, University of Washington, Seattle, USA
    J Am Diet Assoc 109:459-63. 2009
    ..Further studies in larger and more diverse populations are needed to fully understand the potential of this novel intervention approach...
  12. ncbi request reprint Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial
    Alan R Kristal
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    J Urol 177:1395-400; quiz 1591. 2007
    ..We examined risk factors for incident symptomatic benign prostate hyperplasia in 5,667 Prostate Cancer Prevention Trial placebo arm participants who were free of benign prostatic hyperplasia at baseline...
  13. pmc Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial
    Alan R Kristal
    Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Seattle, Washington 98109 1024, USA
    Prostate 70:584-90. 2010
    ..To examine whether androgen receptor (AR) CAG repeat length was associated with the risk of incident benign prostatic hyperplasia (BPH)...
  14. pmc Changes in relative and absolute concentrations of plasma phospholipid fatty acids observed in a randomized trial of Omega-3 fatty acids supplementation in Uganda
    Xiaoling Song
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Electronic address
    Prostaglandins Leukot Essent Fatty Acids 114:11-16. 2016
    ..Both relative weight percentage and absolute concentrations could effectively measure changes in plasma phospholipid fatty acid (PLFA) concentrations...
  15. ncbi request reprint Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials
    Catherine M Tangen
    Catherine M Tangen, Phyllis J Goodman, Cathee Till, and Jeannette M Schenk, Fred Hutchinson Cancer Research Center, Seattle, WA M Scott Lucia, University of Colorado Denver School of Medicine, Denver, CO and Ian M Thompson Jr, The Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX
    J Clin Oncol 34:4338-4344. 2016
    ..Risk factors for prostate cancer derived from epidemiologic studies not only may be erroneous but may lead to misdirected research efforts...
  16. pmc Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
    Wendy E Barrington
    Department of Psychosocial and Community Health, University of Washington, Seattle2Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle3Department of Epidemiology, University of Washington, Seattle
    JAMA Oncol 1:342-9. 2015
    ..African American men have the highest rates of prostate cancer incidence and mortality in the United States. Understanding underlying reasons for this disparity could identify preventive interventions important to African American men...
  17. pmc Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial
    Jeannette M Schenk
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Cancer Causes Control 27:175-82. 2016
    ..We examined whether pre-diagnostic serum androgens were associated with PCA risk in the placebo arm of the Prostate Cancer Prevention Trial...
  18. ncbi request reprint Low-fat, low-glycemic load diet and gene expression in human prostate epithelium: a feasibility study of using cDNA microarrays to assess the response to dietary intervention in target tissues
    Daniel W Lin
    Division of Public Health, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Cancer Epidemiol Biomarkers Prev 16:2150-4. 2007
    ..We examined the feasibility of using gene expression changes in human prostate epithelium as a measure of response to a dietary intervention...
  19. pmc Measurement of Circulating Phospholipid Fatty Acids: Association between Relative Weight Percentage and Absolute Concentrations
    Xiaoling Song
    a Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington
    J Am Coll Nutr 35:647-656. 2016
    ..We aimed to examine the relationship between relative (weight percentage) and absolute (mg/L) concentrations of individual circulating PLFAs...
  20. pmc Brief telephone intervention increases soy intake in peri- and postmenopausal US women: the Herbal Alternatives Trial (HALT)
    Jeannette M Beasley
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave, N M3 A410, PO Box 19024, Seattle, WA 98109 1024, USA
    J Am Diet Assoc 110:1189-97. 2010
    ..The purpose of this study was to describe and evaluate the effectiveness of a telephone-based soy intervention...
  21. ncbi request reprint Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus
    Alan R Kristal
    Fred Hutchinson Cancer Research Center, Cancer Prevention Program, M4 B402, P O Box 19024, Seattle, WA, USA
    Cancer Epidemiol Biomarkers Prev 14:2377-83. 2005
    ..We conclude that substantial dietary change has no short-term effects on biomarkers of cellular proliferation in Barrett esophagus or on clinical observations of the Barrrett segment...
  22. pmc Development and validation of the mindful eating questionnaire
    Celia Framson
    Interdisciplinary Program in Nutritional Sciences, University of Washington, Seattle, USA
    J Am Diet Assoc 109:1439-44. 2009
    ..Its negative association with body mass index and positive association with yoga provide evidence of construct validity. Further evaluation in more diverse populations is warranted...
  23. ncbi request reprint Directions for future epidemiological research in lycopene and prostate cancer risk
    Alan R Kristal
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 4686, USA
    J Nutr 135:2037S-9S. 2005